These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27010402)

  • 1. Hypomagnesemia Following Prolonged Use of Proton-pump Inhibitors.
    Janett S; Bianchetti MG; Milani GP; Lava SA
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):e39. PubMed ID: 27010402
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.
    William JH; Danziger J
    J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypomagnesemia related to the use of omeprazole with negative result for mutation in the TRPM6 gene].
    Fernández-Fernández FJ; Sesma P; Caínzos-Romero T; Ferreira L
    Med Clin (Barc); 2011 Jul; 137(4):188-9. PubMed ID: 21047658
    [No Abstract]   [Full Text] [Related]  

  • 4. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
    Furlanetto TW; Faulhaber GA
    Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
    Semb S; Helgstrand F; Hjørne F; Bytzer P
    World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypomagnesemia and proton pump inhibitors].
    Fumeaux C; Schmidtko J; Meier P
    Rev Med Suisse; 2012 Apr; 8(336):806-10. PubMed ID: 22574415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.
    Regolisti G; Cabassi A; Parenti E; Maggiore U; Fiaccadori E
    Am J Kidney Dis; 2010 Jul; 56(1):168-74. PubMed ID: 20493607
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.
    Ragupathi L; Fonseka N; Sendecki JA; McCarey MM; Breecker SW; Whellan DJ
    Int J Clin Pract; 2015 Dec; 69(12):1525-6. PubMed ID: 26647010
    [No Abstract]   [Full Text] [Related]  

  • 10. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 11. Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.
    Bai JP; Hausman E; Lionberger R; Zhang X
    Mol Pharm; 2012 Dec; 9(12):3495-505. PubMed ID: 23051182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oculogyric crisis in proton pump inhibitor-associated hypomagnesemia.
    Civardi C; Collini A; Geda C
    Parkinsonism Relat Disord; 2020 Mar; 72():80-81. PubMed ID: 32146379
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.
    Swaminathan K
    Indian J Pharmacol; 2015; 47(3):330-1. PubMed ID: 26069375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on "Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?".
    Famularo G
    Ann Pharmacother; 2014 Mar; 48(3):431. PubMed ID: 24586074
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to "Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?".
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2014 Mar; 48(3):432. PubMed ID: 24586075
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atrial fibrillation and QT prolongation due to proton pump inhibitor-induced hypomagnesemia].
    Noirclerc N; Delfanne C; Dompnier A
    Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):201-203. PubMed ID: 32800318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnesium deficiency and proton pump inhibitors].
    Bruserud Ø; Hansen BA
    Tidsskr Nor Laegeforen; 2016 Sep; 136(16):1336. PubMed ID: 27637049
    [No Abstract]   [Full Text] [Related]  

  • 20. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.